| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |